Transforming Drug Design: The Rise of Targeted Protein Degraders

Explore How PROTACs, DACs, and Other Novel Approaches Are Reshaping Pharmaceutical Research

Discover the latest advancements in targeted protein degradation and their potential to transform drug discovery. Our comprehensive white paper explores:

The evolution of PROTACs and their clinical progress

Emerging technologies like LYTACs, AUTACs, and DACs

How these novel approaches are tackling previously "undruggable" proteins

The role of collaboration in accelerating development

Future trends and challenges in the field

Stay at the forefront of pharmaceutical innovation. Fill out the form to access your free copy and unlock insights that could shape the future of drug design.

Send me the latest updates on new product releases, upcoming webinars, and industry insights from Revvity Signals to my inbox. I understand I can unsubscribe or modify my preferences at any time.

By submitting my personal data, I acknowledge that Revvity, Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy.

Get Started

See a live demo

Schedule to see Signals in action

Request a demo

Questions

We're here to help!

Try our products

Take a test drive with a free trial

Free Trials